![M. Isabel Chiu](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
M. Isabel Chiu
Corporate Officer/Principal chez C4 THERAPEUTICS, INC.
Postes actifs de M. Isabel Chiu
Sociétés | Poste | Début | Fin |
---|---|---|---|
C4 THERAPEUTICS, INC. | Corporate Officer/Principal | 01/03/2016 | - |
Historique de carrière de M. Isabel Chiu
Anciens postes connus de M. Isabel Chiu
Sociétés | Poste | Début | Fin |
---|---|---|---|
ENUMERAL BIOMEDICAL HOLDINGS INC | Corporate Officer/Principal | 21/10/2014 | - |
AVEO PHARMACEUTICALS, INC. | Corporate Officer/Principal | - | - |
GPC Biotech, Inc.
![]() GPC Biotech, Inc. Drugstore ChainsRetail Trade GPC Biotech, Inc. discovers and develops anticancer drugs through discovery technologies and development approaches. It is a mechanism-based drug discovery and development company focused on treatments for cancer and fungal infections. The company is a wholly owned subsidiary of GPC Biotech AG. GPC Biotech was founded in 1992 and is located in Waltham, MA. | Corporate Officer/Principal | - | - |
Formation de M. Isabel Chiu
Brandeis University | Undergraduate Degree |
Massachusetts Institute of Technology | Doctorate Degree |
Statistiques
Internationale
Etats-Unis | 7 |
Opérationnelle
Corporate Officer/Principal | 4 |
Undergraduate Degree | 1 |
Doctorate Degree | 1 |
Sectorielle
Health Technology | 4 |
Retail Trade | 2 |
Consumer Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 1 |
---|---|
C4 THERAPEUTICS, INC. | Health Technology |
Entreprise privées | 3 |
---|---|
GPC Biotech, Inc.
![]() GPC Biotech, Inc. Drugstore ChainsRetail Trade GPC Biotech, Inc. discovers and develops anticancer drugs through discovery technologies and development approaches. It is a mechanism-based drug discovery and development company focused on treatments for cancer and fungal infections. The company is a wholly owned subsidiary of GPC Biotech AG. GPC Biotech was founded in 1992 and is located in Waltham, MA. | Retail Trade |
Enumeral Biomedical Holdings, Inc.
![]() Enumeral Biomedical Holdings, Inc. BiotechnologyHealth Technology Enumeral Biomedical Holdings, Inc. is a biopharmaceutical company, which engages in the business of discovering and developing novel antibody immunotherapies for the treatment of cancer and other diseases. It also focuses on the development of a pipeline of next generation monoclonal antibody drugs targeting established and novel immuno-modulatory receptors. The company was founded by Barry C. Buckland, John J. Rydzewski, and Arthur H. Tinkelenberg on December 11, 2009 and is headquartered in Arlington, MA. | Health Technology |
AVEO Pharmaceuticals, Inc.
![]() AVEO Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology AVEO Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the advancement of therapeutics for oncology, and other areas of unmet medical need. Its product candidates include Tivozanib, Ficlatuzmab, AV-203, AV-380 and AV-353. The company was founded by Ronald A. DePinho, Lynda Chin, and Kenneth E. Weg on October 19, 2001 and is headquartered in Cambridge, MA. | Health Technology |
- Bourse
- Insiders
- M. Isabel Chiu
- Expérience